Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DGKA | P23743 | 1/20 | 0.68 |
| ▸ | NAAA | Q02083 | 1/20 | 0.62 |
| ▸ | PAM | P19021 | 2/20 | 0.61 |
| ▸ | GPR84 | Q9NQS5 | 7/20 | 0.59 |
| ▸ | PPARG | P37231 | 7/20 | 0.59 |
| ▸ | PPARD | Q03181 | 7/20 | 0.59 |
| ▸ | PPARA | Q07869 | 7/20 | 0.59 |
| ▸ | HDAC11 | Q96DB2 | 5/20 | 0.59 |
| ▸ | TSHR | P16473 | 4/20 | 0.59 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.59 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.59 |
| ▸ | TLR2 | O60603 | 2/20 | 0.59 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.59 |
| ▸ | FABP4 | P15090 | 2/20 | 0.59 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.59 |
| ▸ | SLC22A8 | Q8TCC7 | 1/20 | 0.59 |
| ▸ | MEN1 | O00255 | 1/20 | 0.59 |
| ▸ | ESR1 | P03372 | 1/20 | 0.59 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.59 |
| ▸ | PDE4A | P27815 | 1/20 | 0.59 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27216286 | 1.00 | DGKA (0.68) | DGKANAAAPAMGPR84PPARG | |
| SCHEMBL27722553 | 1.00 | DGKA (0.68) | DGKANAAAPAMGPR84PPARG | |
| SCHEMBL27328460 | 1.00 | DGKA (0.68) | DGKANAAAPAMGPR84PPARG | |
| SCHEMBL11782956 | 1.00 | DGKA (0.68) | DGKANAAAPAMGPR84PPARG | |
| SCHEMBL20500786 | 1.00 | DGKA (0.68) | DGKANAAAPAMGPR84PPARG | |
| SCHEMBL4953486 | 1.00 | DGKA (0.68) | DGKANAAAPAMGPR84PPARG | |
| SCHEMBL31108662 | 1.00 | DGKA (0.68) | DGKANAAAPAMGPR84PPARG | |
| SCHEMBL31108674 | 1.00 | DGKA (0.68) | DGKANAAAPAMGPR84PPARG | |
| SCHEMBL2894214 | 1.00 | DGKA (0.68) | DGKANAAAPAMGPR84PPARG | |
| SCHEMBL25586645 | 1.00 | DGKA (0.68) | DGKANAAAPAMGPR84PPARG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260069734-A1 | FRESHENING COMPOSITIONS COMPRISING CONTROLLED RELEASE MODULATORS | ARYLESSENCE INC (US) | 2026-03-12 | — | — | US | disclosed |
| CN-114901360-A | Novel lipid nanoparticles for delivery of nucleic acids | 库瑞瓦格股份公司 | 2022-08-12 | — | — | CN | disclosed |
| CN-114874106-A | Amino lipid and preparation method and application thereof | 中山大学附属第七医院(深圳) | 2022-08-09 | — | — | CN | disclosed |
| US-20110301288-A1 | THIOIC ACIDS AS BUILDING BLOCK FOR POLYTHIOESTERS | DSM IP ASSETS B.V. (NL) | 2011-12-08 | — | — | US | disclosed |
| US-20110301288-A1 | THIOIC ACIDS AS BUILDING BLOCK FOR POLYTHIOESTERS | DSM IP ASSETS B.V. (NL) | 2011-12-08 | — | — | US | disclosed |
| US-7060301-B2 | In situ mono-or diester dicarboxylate compositions | ECOLAB INC. (US) | 2006-06-13 | — | — | US | disclosed |
| US-6627593-B2 | A high concentration monoester peroxy dicarboxylic acid composition comprising: 6 wt-% monoester peroxy dicarboxylic acid; about 10 wt-% diester dicarboxylate; anionic surfactant, amine oxide surfactant, or a mixture thereof; hydrogen | ECOLAB INC. | 2003-09-30 | — | — | US | disclosed |
| US-20030087786-A1 | High concentration monoester peroxy dicarboxylic acid compositions, use solutions, and methods employing them | ECOLAB USA INC. | 2003-05-08 | — | — | US | disclosed |
| US-20030021853-A1 | In situ mono-or diester dicarboxylate compositions | ECOLAB USA INC. | 2003-01-30 | — | — | US | disclosed |
| WO-2003005817-A2 | HIGH CONCENTRATION MONOESTER PEROXY DICARBOXYLIC ACID COMPOSITIONS, USE SOLUTIONS, AND METHODS EMPLOYING THEM | ECOLAB INC. (US) | 2003-01-23 | — | — | WO | disclosed |
| WO-2003005818-A1 | IN SITUMONO-OR DIESTER DICARBOXYLATE COMPOSITIONS | ECOLAB INC. (US) | 2003-01-23 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110301288-A1 | THIOIC ACIDS AS BUILDING BLOCK FOR POLYTHIOESTERS | OXER1, OXGR1, HPD | DGKA 1970/4885NAAA 588/4885PAM 65/4885 |
| US-20030021853-A1 | In situ mono-or diester dicarboxylate compositions | DDC, HCAR3, ACMSD | DGKA 109/4885NAAA 88/4885PAM 729/4885 |
| US-20260069734-A1 | FRESHENING COMPOSITIONS COMPRISING CONTROLLED RELEASE MODULATORS | FFAR1, FFAR2, FFAR3 | DGKA 1309/4885NAAA 1321/4885PAM 567/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.